These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 20216093)

  • 1. Infant formula with partial protein hydrolysates: evidence and remaining questions.
    Vandenplas Y
    J Pediatr Gastroenterol Nutr; 2010 Apr; 50(4):356-8. PubMed ID: 20216093
    [No Abstract]   [Full Text] [Related]  

  • 2. Partially hydrolyzed 100% whey protein infant formula and reduced risk of atopic dermatitis: a meta-analysis.
    Alexander DD; Cabana MD
    J Pediatr Gastroenterol Nutr; 2010 Apr; 50(4):422-30. PubMed ID: 20216095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a partially hydrolyzed formula in the dietary prevention of allergic disease.
    Marini A; Agosti M; Colombo C
    Arch Pediatr Adolesc Med; 2006 Aug; 160(8):854-5; author reply 855. PubMed ID: 16894086
    [No Abstract]   [Full Text] [Related]  

  • 4. Economic evaluation of a 100% whey-based, partially hydrolysed formula in the prevention of atopic dermatitis among French children.
    Iskedjian M; Dupont C; Spieldenner J; Kanny G; Raynaud F; Farah B; Haschke F
    Curr Med Res Opin; 2010 Nov; 26(11):2607-26. PubMed ID: 20925454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of a partially hydrolysed 100%-whey infant formula vs. extensively hydrolysed infant formulas in the prevention of atopic dermatitis.
    Iskedjian M; Szajewska H; Spieldenner J; Farah B; Berbari J
    Curr Med Res Opin; 2010 Nov; 26(11):2599-606. PubMed ID: 20925453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified proteins in allergy prevention.
    von Berg A
    Nestle Nutr Workshop Ser Pediatr Program; 2009; 64():239-47; discussion 247-57. PubMed ID: 19710526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New chances in allergy risk: prevention by breastfeeding, HA food and care from the beginning].
    von Weikersthal GF
    Kinderkrankenschwester; 2016 May; 35(5):165-8. PubMed ID: 27430051
    [No Abstract]   [Full Text] [Related]  

  • 8. Meta-analysis of the evidence for a partially hydrolyzed 100% whey formula for the prevention of allergic diseases.
    Szajewska H; Horvath A
    Curr Med Res Opin; 2010 Feb; 26(2):423-37. PubMed ID: 20001576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensively and partially hydrolysed preterm formulas in the prevention of allergic diseases in preterm infants: a randomized, double-blind trial.
    Szajewska H; Mrukowicz JZ; Stoińska B; Prochowska A
    Acta Paediatr; 2004 Sep; 93(9):1159-65. PubMed ID: 15384877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary prevention with hydrolysed formula: does it change natural onset of allergic disease?
    Sinn J; Osborn DA
    Clin Exp Allergy; 2010 Apr; 40(4):534-5. PubMed ID: 20447073
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypersensitivity to hydrolyzed cow's milk protein formula in infants and young children with atopic eczema/dermatitis syndrome with cow's milk protein allergy.
    Kaczmarski M; Wasilewska J; Lasota M
    Rocz Akad Med Bialymst; 2005; 50():274-8. PubMed ID: 16358982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Strict indication is required for partial protein hydrolysates].
    Hernell O; Lönnerdal B
    Lakartidningen; 2016 Jun; 113():. PubMed ID: 27299330
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of atopy and allergic disease: type of infant formula.
    Sampson HA
    Nestle Nutr Workshop Ser Pediatr Program; 2006; 57():109-17; discussion 118-23. PubMed ID: 16632963
    [No Abstract]   [Full Text] [Related]  

  • 14. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long-term results from the German Infant Nutritional Intervention Study (GINI).
    von Berg A; Filipiak-Pittroff B; Krämer U; Link E; Bollrath C; Brockow I; Koletzko S; Grübl A; Heinrich J; Wichmann HE; Bauer CP; Reinhardt D; Berdel D;
    J Allergy Clin Immunol; 2008 Jun; 121(6):1442-7. PubMed ID: 18539195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Early feeding in infancy and atopic dermatitis - a prospective observational study].
    Nentwich I; Pazdírková A; Lokaj J; Szepfalusi Z; Hrstková H
    Klin Padiatr; 2009; 221(2):78-82. PubMed ID: 18270883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extensive and partial protein hydrolysate preterm formulas.
    Szajewska H
    J Pediatr Gastroenterol Nutr; 2007 Dec; 45 Suppl 3():S183-7. PubMed ID: 18185089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond hydrolysates: use of L-amino acid formula in resistant dietary protein-induced intestinal disease in infants.
    Lake AM
    J Pediatr; 1997 Nov; 131(5):658-60. PubMed ID: 9403641
    [No Abstract]   [Full Text] [Related]  

  • 18. Maternal and infant diets for prevention of allergic diseases: understanding menu changes in 2008.
    Sicherer SH; Burks AW
    J Allergy Clin Immunol; 2008 Jul; 122(1):29-33. PubMed ID: 18547624
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cow's milk hydrolyzed formula to infants at risk as good in allergy prevention as human milk].
    Foucard T
    Lakartidningen; 2006 Jan 25-31; 103(4):201. PubMed ID: 16491551
    [No Abstract]   [Full Text] [Related]  

  • 20. A specific mixture of short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides induces a beneficial immunoglobulin profile in infants at high risk for allergy.
    van Hoffen E; Ruiter B; Faber J; M'Rabet L; Knol EF; Stahl B; Arslanoglu S; Moro G; Boehm G; Garssen J
    Allergy; 2009 Mar; 64(3):484-7. PubMed ID: 18507650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.